Psilocybin-Assisted Compassion Focused Therapy for Depression
This paper (2022) makes a case for using Compassion Focused Therapy (CFT) in tandem with psilocybin for the treatment of depression. The authors present a framework for using CFT as well as the rationale for selecting CFT, the compatibility of CFT and psilocybin-therapy, an overview of the psilocybin-assisted CFT protocol, the study protocol, and limitations to this approach.
Authors
- Pots, W.
- Chakhssi, F.
Published
Abstract
Psilocybin-assisted psychotherapy, i.e., psilocybin treatment with psychological support, has demonstrated the efficacy of psilocybin to reduce depressive symptoms. However, in clinical trials, the structure of psilocybin-assisted psychotherapy is primarily based on preparation, navigation (support during dosing sessions), and integration. For psychotherapeutic guidance, the application of this structure is favoured over the usage of theoretical models. The applied psychotherapeutic models may be of critical importance if the effects are augmented due to the psychologically insightful experiences during the navigation and integration sessions. One of the important next steps is to provide therapists with guidance on how to provide psilocybin-assisted psychotherapy. We present an integrated protocol for psilocybin-assisted psychotherapy for depression based on the theoretical model and psychotherapeutic framework of Compassion Focused Therapy (CFT). We hypothesize that CFT can provide the theoretical model and compassion practices that will reinforce the experiences during the navigation and follow-up therapy sessions. In this paper, we describe the rationale for selecting CFT, the compatibility of CFT and psilocybin-therapy, an overview of the psilocybin-assisted CFT protocol, the study protocol, and limitations to this approach.
Research Summary of 'Psilocybin-Assisted Compassion Focused Therapy for Depression'
Introduction
Major depressive disorder remains highly prevalent and burdensome, and current psychotherapies and pharmacotherapies leave many patients without remission. Pots and colleagues note that psilocybin has emerged as a promising intervention for depression: it can alter glutamate signalling in key brain regions, produce changes in self-experience, and increase feelings of connectedness. Clinical trials using psilocybin with psychological support commonly adopt a preparatory–navigation–integration structure, but the psychotherapeutic content has often been non‑directive or minimally specified, and the contribution of an explicit psychotherapeutic model to clinical benefit is unclear. This paper sets out to embed psilocybin-assisted psychotherapy for depression within the theoretical and practical framework of Compassion Focused Therapy (CFT). The study aim is to present the rationale for selecting CFT, describe the compatibility of CFT with psilocybin-assisted therapy, and provide an operationalised treatment protocol and study design suggestions to examine its efficacy and feasibility. The authors propose that CFT practices may reinforce therapeutic processes during navigation (dosing) and integration, thereby enhancing clinical outcomes for depression.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typemeta
- Journal
- Compound
- Topics
- APA Citation
Pots, W., & Chakhssi, F. (2022). Psilocybin-Assisted Compassion Focused Therapy for Depression. Frontiers in Psychology, 13. https://doi.org/10.3389/fpsyg.2022.812930
References (26)
Papers cited by this study that are also in Blossom
Barrett, F. S., Doss, M. K., Sepeda, N. D. et al. · Scientific Reports (2020)
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)
Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)
Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)
Davis, A. K., Barrett, F. S., May, D. G. et al. · JAMA Psychiatry (2021)
Fond, G., Loundou, A., Macgregor, A. et al. · Psychopharmacology (2014)
Forstmann, M., Yudkin, D. A., Prosser, A. M. B. et al. · PNAS (2020)
Palhano-Fontes, F., Gorman, I., Nielson, E. M. et al. · Frontiers in Psychology (2021)
Griffiths, R. R., Johnson, M. W. · Journal of Psychopharmacology (2016)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)
Show all 26 referencesShow fewer
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Holze, F., Avedisian, I., Varghese, N. et al. · Frontiers in Pharmacology (2021)
Horton, D. M., Morrison, B., Schmidt, J. · American Journal of Psychotherapy (2021)
Johnson, M. W., Garcia-Romeu, A., Griffiths, R. R. · The American Journal of Drug and Alcohol Abuse (2016)
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. et al. · Journal of Psychopharmacology (2014)
Johnson, M. W., Griffiths, R. R., Hendricks, P. S. et al. · Neuropharmacology (2018)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Kamboj, S. K., Kilford, E. J., Minchin, S. et al. · Journal of Psychopharmacology (2015)
Mason, N. L., Kuypers, K. P. C., Reckweg, J. et al. · Neuropsychopharmacology (2020)
Nour, M. R., Carhart-Harris, R. L. · British Journal of Psychiatry (2017)
Phelps, J. · Journal of Humanistic Psychology (2017)
Ross, S., Bossis, A. P., Guss, J. et al. · Journal of Psychopharmacology (2016)
Sloshower, J. A. · Plant Medicines Healing and Psychedelic Science (2018)
Sloshower, J., Guss, J., Krause, R. et al. · Journal of Contextual Behavioral Science (2020)
Watts, R., Luoma, J. B. · Journal of Contextual Behavioral Science (2020)
Watts, R., Day, C. M., Krzanowski, J. et al. · Journal of Humanistic Psychology (2017)
Cited By (2)
Papers in Blossom that reference this study
Aicher, H. D., Wicki, I. A., Meling, D. et al. · Journal of Psychopharmacology (2025)
Simonsson, A., Simonsson, O., Chambers, R. et al. · Mindfulness (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.